# Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors

> **NCT01105182** · — · UNKNOWN · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 48 (estimated)

## Conditions studied

- NSCLC
- Pulmonary Metastases

## Interventions

- **PROCEDURE:** Radiofrequency Ablation

## Key facts

- **NCT ID:** NCT01105182
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2010-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105182, "Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01105182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
